
US Pediatricians Defy CDC: Strongly Recommend COVID-19 Shots for Kids!
2025-08-19
Author: Daniel
In a bold move that has sent shockwaves through the healthcare community, the American Academy of Pediatrics (AAP) has issued new vaccine recommendations that now include COVID-19 shots for children aged 6 to 23 months. This divergence from recent guidance issued by the Centers for Disease Control and Prevention (CDC) reflects growing concerns surrounding vaccinations amidst political turmoil.
Back in 2025, Health and Human Services Secretary Robert F. Kennedy Jr. stirred controversy by advising against vaccinations for healthy children and pregnant women, a radical stance that counters decades of public health guidance. Since then, the AAP has taken a stand to prioritize scientific recommendations over politically charged narratives.
The shift in guidance has raised eyebrows, especially after Kennedy replaced influential members of an immunization panel with individuals known for spreading vaccine misinformation. The Advisory Committee on Immunization Practices (ACIP) is set to reassess its childhood vaccination schedule, yet public health experts are alarmed that such changes could hinder access to vital vaccinations.
In a statement affirming its position, AAP President Susan Kressly emphasized that their recommendations are grounded in science and aim to safeguard the health of children. Meanwhile, a spokesperson for HHS accused the AAP of undermining national vaccine policies and urged them to maintain objectivity in their publications.
Adding to the complexity, recent updates to the CDC's website now state that while healthy children "may receive" the COVID-19 vaccine based on healthcare provider judgment, they previously recommended vaccinations for all children 6 months and older.
The AAP’s new schedule also includes significant updates, such as calling for the RSV vaccine for infants under eight months and influenza shots for kids as young as six months in anticipation of the flu season. Additionally, the recommendation for the human papillomavirus (HPV) vaccine is now set for children between 9 to 12 years, lowering the previous starting age of 11.
As confusion mounts for parents navigating these shifting guidelines, questions loom over insurance coverage for vaccinations that the AAP now advocates. Kressly urged insurers to cover all vaccines on this newly established immunization schedule.
Emerging amidst this backdrop is the Vaccine Integrity Project, led by University of Minnesota researchers, which aims to consolidate vaccine data and support organizations like the AAP in developing their immunization guidelines. However, limitations in their analysis have raised concerns around the completeness of information available to parents and healthcare providers.
Dr. Jake Scott, an infectious disease specialist at Stanford University, acknowledged the ongoing efforts to ensure comprehensive safety assessments regarding vaccines. With the stakes higher than ever, the debate over childhood vaccinations continues to intensify, highlighting the need for clear, evidence-based guidance in these uncertain times.